Have a Claim?

Click here for a confidential contact or call:

1-212-350-2774

Government Enforcement Actions

Please also see our Recent Government Enforcement Actions page.

Page 484 of 533

March 14, 2014

Isabel Medina, the owner and operator of the Miami medical clinic Merfi Corp., was sentenced to serve 108 months in prison and pay $8.5M for her participation in multiple health care fraud schemes totaling $20M. DOJ

March 13, 2014

Memorial Hospital, the operator of an acute care hospital facility in Ohio, agreed to pay $8.5M to settle claims that it violated the False Claims Act, the Anti-Kickback Statute and the Stark Statute by engaging in improper financial relationships with referring physicians. DOJ

Tagged in: Anti-Kickback and Stark, FCA Federal, Hospital Fraud,

March 12, 2014

A federal jury in Houston convicted two owners of a former Houston mental health care company, Spectrum Care, several of its employees and the owners of certain Houston group care homes for their participation in a $97M Medicare fraud scheme. DOJ

March 11, 2014

Generic pharmaceutical giant Teva Pharmaceuticals and its IVAX subsidiary have agreed to pay $27.6M for allegedly violating the False Claims Act by making payments to induce prescriptions of an anti-psychotic drug for Medicare and Medicaid beneficiaries. DOJ

Tagged in: FCA Federal, Pharma Fraud,

March 7, 2014

Ocean shipping companies Sea Star Line and Horizon Lines agreed to pay $1.9M and $1.5M, respectively, to resolve allegations that they violated the False Claims Act by fixing the price of government cargo transportation contracts between the continental US and Puerto Rico, the Department of Justice announced today. The allegations were first raised in a qui tam lawsuit filed under the whistleblower provisions of the False Claims Act. DOJ

Tagged in: Bribery and Bid-Rigging, FCA Federal, Government Procurement Fraud, Whistleblower Case,

February 27, 2014

Omnicare Inc., an Ohio-based long-term care pharmacy, agreed to pay $4.2M to settle allegations that it engaged in a kickback scheme in violation of the False Claims Act. The allegations were first raised in a qui tam lawsuit filed under the whistleblower provisions of the False Claims Act.DOJ

Tagged in: Anti-Kickback and Stark, FCA Federal, Pharma Fraud, Whistleblower Case,

February 27, 2014

CSAV, a Chilean corporation, agreed to plead guilty pay an $8.9M criminal fine for its involvement in a conspiracy to fix prices, allocate customers and rig bids of international ocean shipping services for roll-on, roll-off cargo, such as cars and trucks, to and from the United States and elsewhere. DOJ

February 25, 2014

Diagnostic Imaging Group agreed to pay $15.5M to resolve allegations that its diagnostic testing facility falsely billed federal and state health care programs for tests that were not performed or not medically necessary and by paying kickbacks to physicians. The allegations were first raised in three qui tam lawsuits filed under the whistleblower provisions of the False Claims Act. DOJ

Tagged in: Anti-Kickback and Stark, FCA Federal, Laboratory and IDTF, Lack of Medical Necessity, Medical Billing Fraud, Whistleblower Case,

February 21, 2014

Endo Pharmaceuticals and its parent Endo Health Solutions agreed to pay $192.7M to resolve criminal and civil liability arising from Endo’s marketing of the prescription drug Lidoderm for uses not approved as safe and effective by the FDA. The allegations were first raised in three qui tam lawsuits filed under the whistleblower provisions of the False Claims Act. DOJ

Tagged in: FCA Federal, Off-Label and Unapproved Use, Pharma Fraud, Whistleblower Case,

February 19, 2014

Medical device manufacturer EndoGastric Solutions agreed to pay up to $5.25M to resolve allegations that it violated the False Claims Act by misleading health care providers about how to bill federal health care programs for a procedure using a device manufactured by the company and by paying kickbacks. The allegations were first raised in a qui tam lawsuit filed under the whistleblower provisions of the False Claims Act. DOJ

Tagged in: FCA Federal, Medical Billing Fraud, Medical Devices and DME, Whistleblower Case,

1 … 482 483 484 485 486 … 533

Newsletter

Subscribe to receive email updates from the Constantine Cannon blogs

Sign up for: